Rajeev Seth, MD
Retina Specialist · Liverpool, NYNPI 1073710737
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (57.4%), ownership interests and food and beverage — rather than concentrated in one kind of arrangement. US Retina LLC accounts for 98.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $10,638 and has fallen 99.1% since, to $93 in 2024.
Across 12 payments — averaging $1207.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$14K
- Regeneron Healthcare Solutions, Inc.$130
- Astellas Pharma US Inc$34
- AbbVie$18
What the payments were for
- Food & beverage$1821%
- Ownership interest$5,99241%
- Other$8,31557%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 7 | $14,307 |
| Regeneron Healthcare Solutions, Inc. | 3 | $130 |
| Astellas Pharma US Inc | 1 | $34 |
| AbbVie | 1 | $18 |
How this compares
$14,489 in reported general payments places this provider in the 80th percentile of 99 retina specialist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 102 | $4,322 |
| Loteprednol Etabonate | 14 | $2,665 |
| Ketorolac Tromethamine | 51 | $1,277 |
| Dorzolamide Hcl | 33 | $776 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 29 | $362 |
| Tobramycin | 56 | $313 |
| Timolol Maleate | 26 | $309 |
| Diclofenac Sodium | 28 | $235 |
| Latanoprost | 21 | $178 |
| Brimonidine Tartrate | 31 | $155 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Liverpool
- Mark BreazzanoLiverpool$30K
- Jamin BrownLiverpool$18K
- Patrick OellersLiverpool$17K
- Bryan RutledgeLiverpool$15K
- Samuel SpaldingLiverpool$15K
- Kevin RosenbergLiverpool$14K
- Paul HahnNanuet$238K
- Deepika MalikWoodbury$221K
- Szilard KissNew York$195K
- Ferhina AliValhalla$176K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.